C-IU8NShift Bioscience
cell rejuvenation, aging clocks, siRNA therapeutics
reprogrammingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-IU8N
C-IU8NC-IU8Ncell rejuvenation, aging clocks, siRNA therapeutics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Shift Bioscience states that population aging is driving unsustainable levels of poor health and healthcare cost, and that this trend should be reversed through rejuvenation interventions. The company presents cellular reprogramming as a uniquely powerful way to reset aged cells and tissues toward a youthful state, but argues that its central challenge is safety: too little reprogramming yields no rejuvenation, while too much creates cancer risk. Their stated belief is that machine learning can solve this 'goldilocks problem' and enable safe rejuvenation therapies that could broadly address age-associated disease.
SourceShift Bioscience states that aging is the fundamental driver of rising disease burden and healthcare costs, and that current therapies mostly treat symptoms rather than underlying causes. The company argues that molecular-level study of aging, especially through epigenetic tools and aging clocks, can identify which hallmarks of aging are true root causes versus downstream consequences. It further states that interventions aimed at the most central hallmarks, as measured by their effect on the epigenetic aging clock, should have the greatest impact on slowing or reversing aging processes and improving therapies for age-related disease.
SourceShift Bioscience states that mitochondria are the body’s main energy producers and that damage accumulating over life in mitochondrial DNA contributes to aging, reduced energy, and disease. The company presents the view that maintaining mitochondrial health is important for fitness and health, that lifestyle and diet may help preserve mitochondrial energy output by increasing mitochondrial number, and that technology should be developed to identify and repair damaged mitochondrial DNA.
SourceShift Bioscience states that it is developing small molecules intended to reverse visible aging and increase healthy lifespan, initially focusing on skin care because advanced 3D skin models enable faster optimization and the facial anti-aging market offers strong commercial potential. The company argues that aging involves abrupt, non-linear shifts in cellular bioenergetic, epigenetic, and transcriptional states, and that restoring earlier-life functional states by modulating these "state shifts" can improve cell and tissue function without changing cell identity.
SourceShift Bioscience states that aging involves abrupt, non-linear changes in the bioenergetic, epigenetic, and transcriptional states of cells and tissues, and that restoring earlier-life functional cellular states can reverse visible aging. The company says it targets stressors and pathways linked to these age-related state changes and believes that modulating them with small molecules, guided by technologies such as the epigenetic aging clock, is the most effective way to reverse visible aging.
Source